Lian indicated the oral VK2735 program is expected to advance into Phase III for obesity, with initiation targeted for the third quarter of 2026. "We currently expect to initiate this program in the ...

Agency Feedback Provides Regulatory Clarity on Enrichment Strategy and Confirms CDR-SB as Sole Primary Endpoint for Registrational ...

The Bioxyytran Trial reports complete elimination of viral load in 100% of patients at day 7 versus placebo (p=.001). Boston, ...

Lucknow: To monitor the upcoming Film City project along the Yamuna Expressway, the Yamuna Expressway Industrial Development ...

Amazon Web Services is the world’s most comprehensive and broadly adopted cloud, enabling customers to build almost anything they can imagine. Amazon AWS offers the greatest choice of innovative cloud ...

Tuebingen, Germany, February 11, 2026 - HepaRegeniX GmbH ('HepaRegeniX”), a clinical-stage biotech company advancing novel therapies for acute and chronic liver diseases, today announced the ...

Work will start on the long-delayed final phase of a problem-plagued Blackburn housing estate next month 16 years after the regeneration scheme was first conceived.

Crypto market behavior in 2026 reflects a clear change in priorities. Attention cycles still exist, but sustained interest increasingly tracks projects that dem ...

Regulated healthcare companies are under increasing pressure to move faster while maintaining the highest standards of ...

Caylent Named Development Partner to Lead AWS-Native Build Roseland, NJ, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applic ...

PF'3944 is an ultra-long-acting fully biased GLP-1 receptor agonist (RA). It is being developed as a single agent weekly and as a monthly therapy, and in combination with various peptides including an ...